Financials

News Discussions Technicals Seasonals

115180 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Qurient Co., Ltd. engages in the development of novel therapeutics. Its research and development pipeline includes multiple drug resistance tuberculosis, atopic dermatitis, asthma, and cancer. The company was founded by Ki-Yean Nam on July 2, 2008 and is headquartered in Seongnam-si, South Korea.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

115180 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company